Qvella Corporation Stock

Qvella is a molecular diagnostics company with the goal of dramatically reducing time to results in bacteriology.

Sign up today and learn more about Qvella Corporation Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Qvella Corporation Stock

Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

Funding History

March 2015$2.0M
October 2015$20.0M
December 2017$25.0M

Management

President and CEO

Tino Alavie

Chief Scientist

Samad Talebpour

Vice President

Robert Maaskant

Senior Scientist

Aye Aye Khine

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo